{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:34:54Z","timestamp":1788348894125,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802553"],"award-info":[{"award-number":["81802553"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.prp.2023.154536","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:57:52Z","timestamp":1684209472000},"page":"154536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"247","author":[{"given":"Li-Juan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Bin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Han","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Peng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.prp.2023.154536_bib1","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"S0140\u20136736","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"issue":"20","key":"10.1016\/j.prp.2023.154536_bib4","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1158\/1078-0432.CCR-14-1215","article-title":"Invasive bladder cancer: genomic insights and therapeutic promise","volume":"21","author":"Kim","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"35","key":"10.1016\/j.prp.2023.154536_bib5","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1200\/JCO.2006.08.5431","article-title":"Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments","volume":"24","author":"Parekh","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2023.154536_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrurol.2015.231","article-title":"Targeted therapies in bladder cancer: an overview of in vivo research","volume":"12","author":"van Kessel","year":"2015","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.prp.2023.154536_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.urolonc.2020.11.021","article-title":"Bladder preservation: translating discovery for clinical impact in urothelial cancer","volume":"39","author":"Miyamoto","year":"2021","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0973-1482.140982","article-title":"Survival trends in metastatic bladder cancer in the United States: a population based study","volume":"11","author":"Shah","year":"2015","journal-title":"J. Cancer Res. Ther."},{"issue":"10","key":"10.1016\/j.prp.2023.154536_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41568-022-00497-8","article-title":"Oncofetal reprogramming in tumour development and progression","volume":"22","author":"Sharma","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbamcr.2008.05.013","article-title":"Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis","volume":"1793","author":"Merkwirth","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prp.2023.154536_bib11","doi-asserted-by":"crossref","first-page":"17059","DOI":"10.1038\/sigtrans.2017.59","article-title":"Prohibitin: a potential therapeutic target in tyrosine kinase signaling","volume":"2","author":"Ande","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2023.154536_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-030-57362-1_5","article-title":"The oncogenic role of hepatitis C virus","volume":"217","author":"Koike","year":"2021","journal-title":"Recent Results Cancer Res."},{"issue":"8","key":"10.1016\/j.prp.2023.154536_bib13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/pmic.200900757","article-title":"Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: molecular mechanisms and functional implications","volume":"10","author":"S\u00e1nchez-Quiles","year":"2010","journal-title":"Proteomics"},{"issue":"8","key":"10.1016\/j.prp.2023.154536_bib14","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","article-title":"Mitophagy in tumorigenesis and metastasis","volume":"78","author":"Poole","year":"2021","journal-title":"Cell Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.prp.2023.154536_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083519","article-title":"Induction of paclitaxel resistance by ERalpha mediated prohibitin mitochondrial-nuclear shuttling","volume":"8","author":"Dong","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12943-022-01611-y","article-title":"circFBXO7\/miR-96-5p\/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2023.154536_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.40","article-title":"Akt phosphorylates prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.prp.2023.154536_bib18","first-page":"278","article-title":"Brusatol modulates diverse cancer hallmarks and signaling pathways as a potential cancer therapeutic","volume":"1","author":"Guo","year":"2022","journal-title":"Acta Mater. Med."},{"issue":"3","key":"10.1016\/j.prp.2023.154536_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib20","first-page":"56","article-title":"Advances in therapeutic agents targeting quiescent cancer cells","volume":"1","author":"Nik Nabil","year":"2022","journal-title":"Acta Mater. Med."},{"issue":"2","key":"10.1016\/j.prp.2023.154536_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-2050.2009.01001.x","article-title":"Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma","volume":"23","author":"Ren","year":"2010","journal-title":"Dis. Esophagus"},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/\u03b2-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00280-021-04270-w","article-title":"Upregulation of TRIB2 by Wnt\/\u03b2-catenin activation in BRAFV600E papillary thyroid carcinoma cells confers resistance to BRAF inhibitor vemurafenib","volume":"88","author":"Wang","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","article-title":"MG132, a proteasome inhibitor, induces apoptosis in tumor cells","volume":"9","author":"Guo","year":"2013","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2023.154536_bib25","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.7150\/thno.41383","article-title":"A novel function of prohibitin on melanosome transport in melanocytes","volume":"10","author":"Jo","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2023.154536_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-13-38","article-title":"Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma","volume":"13","author":"Luan","year":"2014","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/10799893.2012.752006","article-title":"Signaling pathways of prohibitin and its role in diseases","volume":"33","author":"Luan","year":"2013","journal-title":"J. Recept Signal Transduct. Res."},{"issue":"3","key":"10.1016\/j.prp.2023.154536_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15548627.2019.1628520","article-title":"PHB2 (prohibitin 2) promotes PINK1-PRKN\/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis","volume":"16","author":"Yan","year":"2020","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.prp.2023.154536_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ncb2976","article-title":"Oncogenic roles of EMT-inducing transcription factors","volume":"16","author":"Puisieux","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13046-020-01690-z","article-title":"TM4SF1 promotes EMT and cancer stemness via the Wnt\/\u03b2-catenin\/SOX2 pathway in colorectal cancer","volume":"39","author":"Tang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154536_bib31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00280-021-04322-1","article-title":"Targeting cPLA2\u03b1 inhibits gastric cancer and augments chemotherapy efficacy via suppressing Ras\/MEK\/ERK and Akt\/\u03b2-catenin pathways","volume":"88","author":"Liao","year":"2021","journal-title":"Cancer Chemother. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2023.154536_bib32","doi-asserted-by":"crossref","first-page":"a007898","DOI":"10.1101\/cshperspect.a007898","article-title":"The beta-catenin destruction complex","volume":"5","author":"Stamos","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823002364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T07:01:35Z","timestamp":1759734095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823002364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":32,"alternative-id":["S0344033823002364"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154536","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PHB promotes bladder cancer cell epithelial-mesenchymal transition via the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154536"}}